Literature DB >> 20185512

Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system.

M Valeria Bahamondes1, Ilza Monteiro, Sara Castro, Ximena Espejo-Arce, Luis Bahamondes.   

Abstract

BACKGROUND: The levonorgestrel-releasing intrauterine system (LNG-IUS) induces amenorrhoea, and its effect on bone mineral density (BMD) may constitute a concern. This study evaluated BMD in long-term users of the LNG-IUS or intrauterine device (IUD).
METHODS: BMD was evaluated at the midshaft of the ulna and ultra-distal radius using dual-energy X-ray absorptiometry in 37 women at 7 or 10 years of use following placement of a second LNG-IUS. The groups were paired for duration of use, age, body mass index (BMI), ethnicity and number of pregnancies.
RESULTS: The mean age of both LNG-IUS and IUD users at the 7th and 10th year was approximately 34 and 38 years, respectively. Mean BMI was approximately 25 in both groups, increasing to approximately 26 at the 10th year. Amenorrhoea occurred in 51.4 and 91.9% of LNG-IUS users at the 7th and 10th year, respectively. Estradiol levels in LNG-IUS users were normal at both evaluations. There were no differences in BMD (g/cm(2)) at the midshaft of the ulna nor ultra-distal radius between LNG-IUS and IUD users or between the 7th and 10th years of use in LNG-IUS users. A Z-score below -2SD at the ultra-distal radius was observed in only one LNG-IUS user and in none of the IUD users at the 10th year. Higher BMI and BMD at the seventh year and amenorrhoea were predictors of higher BMD at the 10th year.
CONCLUSIONS: BMD at the midshaft of the ulna and ultra-distal radius in LNG-IUS users were similar to that of IUD users and remained unchanged between the 7th and the 10th years of use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185512     DOI: 10.1093/humrep/deq043

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

Review 1.  Progestin-only contraceptives: effects on weight.

Authors:  Laureen M Lopez; Alison Edelman; Mario Chen; Conrad Otterness; James Trussell; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2013-07-02

Review 2.  Update on hormonal contraception and bone density.

Authors:  Michelle M Isley; Andrew M Kaunitz
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

3.  Commonly Prescribed and Over-the-Counter Drugs as Secondary Causes of Osteoporosis-Part Two.

Authors:  Joseph Pizzorno; Lara Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2021-06

4.  Role of the levonorgestrel intrauterine system in effective contraception.

Authors:  Abdelhamid M Attia; Magdy M Ibrahim; Ahmed M Abou-Setta
Journal:  Patient Prefer Adherence       Date:  2013-08-09       Impact factor: 2.711

5.  Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.

Authors:  O Heikinheimo; P Inki; T Schmelter; K Gemzell-Danielsson
Journal:  Hum Reprod       Date:  2014-03-28       Impact factor: 6.918

Review 6.  Progestin-only contraceptives: effects on weight.

Authors:  Laureen M Lopez; Shanthi Ramesh; Mario Chen; Alison Edelman; Conrad Otterness; James Trussell; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2016-08-28

Review 7.  New developments in intrauterine device use: focus on the US.

Authors:  Anita L Nelson; Natasha Massoudi
Journal:  Open Access J Contracept       Date:  2016-09-13

Review 8.  Hormonal Contraception and Bone Health in Adolescents.

Authors:  Laura K Bachrach
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-21       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.